ARTICLE | Clinical News
Roniciclib: Phase II discontinued
October 17, 2016 7:00 AM UTC
Bayer discontinued the double-blind, international Phase II CONCEPT-SLCL trial in 140 chemotherapy-naive patients with extensive disease SCLC after oral roniciclib plus chemotherapy missed the primary...